Mireia Pesarrodona
Project Leader at Nuage Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Nuage Therapeutics
-
Spain
-
Biotechnology Research
-
1 - 100 Employee
-
Project Leader
-
Apr 2022 - Present
-
-
-
IRB Barcelona
-
Spain
-
Research Services
-
300 - 400 Employee
-
-
Jun 2018 - Present
-
-
-
Jun 2017 - Jun 2018
-
-
-
-
Research Assistant
-
Jan 2017 - Jun 2017
Involved in the development of protein-based nanoparticles targeted to breast and colorectal cancer. This includes recombinant protein production (E. coli system), purification (FPLC), physicochemical characterisation (DLS, SDS-PAGE, Western, Fluorescence) and drug conjugation; as well as, in vitro activity assessment in cancer cell lines (MTT, Flow Cytometry). PhD student mentoring Involved in the development of protein-based nanoparticles targeted to breast and colorectal cancer. This includes recombinant protein production (E. coli system), purification (FPLC), physicochemical characterisation (DLS, SDS-PAGE, Western, Fluorescence) and drug conjugation; as well as, in vitro activity assessment in cancer cell lines (MTT, Flow Cytometry). PhD student mentoring
-
-
-
Universitat Autònoma de Barcelona
-
Spain
-
Higher Education
-
700 & Above Employee
-
Researcher (PhD Thesis)
-
Apr 2012 - Jan 2017
-
-
-
Cranfield University
-
United Kingdom
-
Higher Education
-
700 & Above Employee
-
Researcher (MSc Thesis)
-
Jan 2011 - Jul 2011
‘Development of an ‘exploitable proteome’ resource for Bacillus anthracis’: Generation of a complete functional -omics view of the pathogen Bacillus anthracis through the identification of potential targets, using an in-silico methodology based on a protein of interest selection followed by a homology study and an epitope identification, for the detection, prevention and treatment of anthrax. ‘Development of an ‘exploitable proteome’ resource for Bacillus anthracis’: Generation of a complete functional -omics view of the pathogen Bacillus anthracis through the identification of potential targets, using an in-silico methodology based on a protein of interest selection followed by a homology study and an epitope identification, for the detection, prevention and treatment of anthrax.
-
-
-
Arquebio S.L.
-
Spain
-
Biotechnology Research
-
1 - 100 Employee
-
Research Assistant
-
Jun 2010 - Aug 2010
Involved in a project development based on the design of a multi-recombinant protein for the treatment and prevention of Candida albicans infection. Cell line maintenance and cell culture experiments. Involved in a project development based on the design of a multi-recombinant protein for the treatment and prevention of Candida albicans infection. Cell line maintenance and cell culture experiments.
-
-
-
Universitat de Lleida
-
Spain
-
Higher Education
-
700 & Above Employee
-
Research Assistant
-
Jul 2008 - Dec 2008
Involved in two main tasks: - development and preparation of on-line academic material in organic chemistry for university students (computer-based)_50% - research on biodiesel synthesis from organic oil waste (lab-based)_50% Involved in two main tasks: - development and preparation of on-line academic material in organic chemistry for university students (computer-based)_50% - research on biodiesel synthesis from organic oil waste (lab-based)_50%
-
-
Education
-
EMBO
Project Management for Scientists, Project Management -
Universitat Autònoma de Barcelona
Doctor of Philosophy (PhD), Biotecnología -
Cranfield University
MSc, Molecular Medicine -
Universitat de Lleida
BSc, Biotechnology